Wyeth received Food and Drug Administration approval for its antidepressant Pristiq, keeping the company in a lucrative niche as a big-selling predecessor drug faces competition from generics in coming years.

As per WyethThe drug is a "refinement" of the company's hugely successful Effexor XR rather than a medication based on a new mechanism.